Consorzio Interuniversitario Nazionale per la Bio-Oncologia www.cinbo.org
DIRECTOR Clara Natoli SCIENTIFIC SECRETARIAT
Consiglia Carella Michele De Tursi Antonino Grassadonia
Nicola Tinari
SCIENTIFIC ADVISORY BOARD Vincenzo Adamo
Barbara Barboni Roberto Bianco Giovanni Brandi Marco Carini Leonardo Della Salda
Corrado Ficorella Francesco Grignani
Lorenzo Lo Muzio Patrizia Querzoli
Antonio Russo Marina Scarpelli
Silverio Tomao Giuseppe Tonini ORGANIZING SECRETARIAT
Giovanna Di Credico OFFICES
Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio - Via dei Vestini, 31
66100 Chieti - Italy Phone: +39 0871 3556732
Fax +39 0871 3556707 [email protected] PROVIDER ECM ID. 50
Strategie S.r.L. - Via Piave 110/7 - Pescara Phone: 085 74143 - Fax: 085 378220
[email protected] www.strategieonweb.it
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
presents
TOWARDS PRECISION MEDICINE IN CANCER
TREATMENT
May 26, 2017
Auditorium c/o Rettorato
Università degli Studi “G. D’Annunzio”
Via dei Vestini, 31 Chieti
Directors
Paolo Marchetti & Clara Natoli
CINBO
Consorzio Interuniversitario Nazionale per la Bio-Oncologia
Evento n. ECM 50-190187 per Medici Chirurghi specialisti in:
ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; DERMATOLOGIA E VENEREOLOGIA; EMATOLOGIA; ENDOCRINOLOGIA; GENETICA
MEDICA; MALATTIE DELL’APPARATO RESPIRATORIO; MEDICINA INTERNA; NEFROLOGIA; ONCOLOGIA; RADIOTERAPIA; CHIRURGIA
GENERALE; CHIRURGIA PLASTICA E RICOSTRUTTIVA; CHIRURGIA TORACICA; GINECOLOGIA E OSTETRICIA; UROLOGIA; ANATOMIA
PATOLOGICA; FARMACOLOGIA E TOSSICOLOGIA CLINICA;
MEDICINA NUCLEARE; PATOLOGIA CLINICA (LABORATORIO DI ANALISI CHIMICOCLINICHE E MICROBIOLOGIA);
RADIODIAGNOSTICA; IGIENE, EPIDEMIOLOGIA E SANITÀ PUBBLICA; CURE PALLIATIVE; EPIDEMIOLOGIA;
per Farmacisti (Farmacia Ospedaliera); per Biologi Crediti ECM: 6
si ringrazia per il contributo incondizionato:
La partecipazione è gratuita.
Le iscrizioni si accettano esclusivamente on line sul sito del Provider www.strategieonweb.it - pagina ECM 2017
Con il patrocino di:
Stampa Demagraf - Pescara
9.00 Registration & Wellcome coffee
9.30 Opening Paolo Marchetti & Clara Natoli
Chair: Amedeo Pancotti and Nicola Tinari
09.50 The near future: P4 Medicine Saverio Alberti
10.10 Precision medicine-based clinical trials Clara Natoli
10.20 The impact of next-generation sequencing on precision medicine Antonio Marchetti
10.40 Discussion leaders Francesco Grignani & Paolo Marchetti
11.00 Coffee break
Chair: Teresa Martino and Lucio Laudadio
11.40 Molecular subtypes of colorectal cancer: applications in diagnosis and treatment Mario Scartozzi 12.00 Genomic profi ling of prostate, colon and ovarian cancer: ready for prime? Daniele Zanoni
12.20 Discussion leaders Corrado Ficorella & Giovanni Brandi
12.40 Lecture
Cancer immunotherapy and precision medicine Marianna Nuti
13.30 Light Lunch
Chair: Katia Cannita and Luciana Irtelli
14.30 ALK and ROS1 kinase inhibitors: molecular mechanisms of resistance Rita Chiari
14.50 MET receptor inhibition in solid tumors Roberto Bianco
15.10 Discussion leaders Riccardo Giampieri & Mario Roselli
Chair: Michele De Tursi and Luca Cindolo
15.30 Targeting castration-resistant prostate cancer Arcangelo Sebastianelli
15.50 BRAF and MEK inhibitors Antonio Grimaldi
16.10 Discussion leaders Silverio Tomao & Vincenzo Adamo
16.30 Coffee break
Chair: Antonino Grassadonia and Consiglia Carella
16.45 DNA Repair pathways as targets for cancer therapy Domenica Lorusso 17:05 Biological and clinical impact of cancer stem cells in ovarian cancer Federica Tomao
17.25 RANK as a therapeutic target in cancer Francesco Pantano
17.45 Discussion leaders Giuseppe Tonini & Matteo Landriscina
18:05 Conclusions Paolo Marchetti & Clara Natoli
18.15 ECM
Program Faculty
Vincenzo Adamo [email protected] Messina Saverio Alberti [email protected] Chieti
Roberto Bianco [email protected] Napoli
Giovanni Brandi [email protected] Bologna
Katia Cannita [email protected] L’Aquila
Consiglia Carella [email protected] Chieti
Rita Chiari [email protected] Perugia
Luca Cindolo [email protected] Chieti
Michele De Tursi [email protected] Chieti
Corrado Ficorella corrado.fi [email protected] L’Aquila
Riccardo Giampieri
[email protected] Ancona
Antonino Grassadonia [email protected] Chieti
Antonio Grimaldi
[email protected] Napoli
Francesco Grignani [email protected] Perugia
Matteo Landriscina [email protected] Foggia
Lucio Laudadio
[email protected] Lanciano
Domenica Lorusso
[email protected] Milano
Luciana Irtelli [email protected] Chieti
Antonio Marchetti [email protected] Chieti
Paolo Marchetti
[email protected] Roma
Maria Teresa Martino [email protected] Chieti
Clara Natoli [email protected] Chieti Marianna Nuti
[email protected] Roma
Amedeo Pancotti [email protected] Teramo
Francesco Pantano [email protected] Roma
Mario Roselli
[email protected] Roma
Mario Scartozzi
[email protected] Monserrato Cagliari Arcangelo Sebastianelli
[email protected] Firenze
Nicola Tinari [email protected] Chieti Federica Tomao
[email protected] Roma
Silverio Tomao
[email protected] Roma
Giuseppe Tonini [email protected] Roma
Daniele Zanoni [email protected] Cremona
9.00 Registration & Wellcome coffee 9.30 Opening
09.50 The near future: P4 Medicine
10.10 Precision medicine-based clinical trials
10.20 The impact of next-generation sequencing on precision medicine 10.40 Discussion leaders
11.00
11.40 Molecular subtypes of colorectal cancer: applications in diagnosis and treatment 12.00 Genomic profi ling of prostate, colon and ovarian cancer: ready for prime?
12.20 Discussion leaders 12.40 Lecture
13.30
14.30 ALK and ROS1 kinase inhibitors: molecular mechanisms of resistance 14.50 MET receptor inhibition in solid tumors
15.10 Discussion leaders
16.30
15.30 Targeting castration-resistant prostate cancer 15.50 BRAF and MEK inhibitors
16.10 Discussion leaders
16.45 DNA Repair pathways as targets for cancer therapy
17:05 Biological and clinical impact of cancer stem cells in ovarian cancer 17.25 RANK as a therapeutic target in cancer
17.45 Discussion leaders 18:05 Conclusions 18.15 ECM
